Acquired by Gurnet Point Capital and Patient Square Capital in Aug 2022
RDUS - Radius Health, Inc.
NASDAQ
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
Boston,
United States
Type: Equity
RDUS price evolution
RDUS
| (in millions $) | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $73.06 | $72.18 | $112.1 | $110.13 |
| Short term investments | ||||
| Net receivables | $32.01 | $30.28 | $23.36 | $26.55 |
| Inventory | $12.49 | $13.3 | $11.37 | $11.6 |
| Total current assets | $146.41 | $145.77 | $173.08 | $177.48 |
| Long term investments | ||||
| Property, plant & equipment | $1.74 | $1.74 | $1.48 | $1.38 |
| Goodwill & intangible assets | $4.59 | $4.79 | $4.99 | $5.19 |
| Total noncurrent assets | $8.03 | $8.38 | $8.46 | $8.71 |
| Total investments | ||||
| Total assets | $154.44 | $154.15 | $181.54 | $186.18 |
| Current liabilities | ||||
| Accounts payable | $14.48 | $15.79 | $17.63 | $13.55 |
| Deferred revenue | ||||
| Short long term debt | $0.42 | $0.51 | $0.61 | $0.72 |
| Total current liabilities | $87.86 | $80.46 | $94.79 | $90.04 |
| Long term debt | $339.98 | $339.63 | $339.06 | $338.69 |
| Total noncurrent liabilities | $339.98 | $339.63 | $339.06 | $338.69 |
| Total debt | $340.4 | $340.14 | $339.67 | $339.42 |
| Total liabilities | $427.84 | $420.1 | $433.85 | $428.73 |
| Shareholders' equity | ||||
| Retained earnings | -$1398.99 | -$1386.26 | -$1367.98 | -$1352.4 |
| Other shareholder equity | $0.05 | $0.01 | ||
| Total shareholder equity | -$273.4 | -$265.95 | -$252.3 | -$242.55 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $112.1 | $92 | $70.45 | $59.88 |
| Short term investments | $23.28 | $91.02 | $177.14 | |
| Net receivables | $23.36 | $20.31 | $23.29 | $16.76 |
| Inventory | $11.37 | $9.17 | $5.32 | $6.21 |
| Total current assets | $173.08 | $180.55 | $203.06 | $275.03 |
| Long term investments | ||||
| Property, plant & equipment | $1.48 | $4.73 | $9 | $4 |
| Goodwill & intangible assets | $4.99 | $5.79 | $6.58 | $7.38 |
| Total noncurrent assets | $8.46 | $11.03 | $16.09 | $11.93 |
| Total investments | $23.28 | $91.02 | $177.14 | |
| Total assets | $181.54 | $191.58 | $219.15 | $286.96 |
| Current liabilities | ||||
| Accounts payable | $17.63 | $9.93 | $6.03 | $4.23 |
| Deferred revenue | $1 | |||
| Short long term debt | $0.61 | $2.49 | $2.2 | |
| Total current liabilities | $94.79 | $73.17 | $61.26 | $46.43 |
| Long term debt | $339.06 | $242.07 | $200.17 | $179.81 |
| Total noncurrent liabilities | $339.06 | $242.07 | $200.17 | $179.9 |
| Total debt | $339.67 | $244.56 | $202.37 | $179.81 |
| Total liabilities | $433.85 | $315.24 | $261.43 | $226.33 |
| Shareholders' equity | ||||
| Retained earnings | -$1367.98 | -$1345.82 | -$1236.61 | -$1103.62 |
| Other shareholder equity | $0.02 | $0 | -$0.76 | |
| Total shareholder equity | -$252.3 | -$123.66 | -$42.28 | $60.63 |
| (in millions $) | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $58.28 | $43.16 | $65.11 | $56.81 |
| Cost of revenue | $5.58 | $4.26 | $5.36 | $5.07 |
| Gross Profit | $52.71 | $38.9 | $59.75 | $51.74 |
| Operating activities | ||||
| Research & development | $26.31 | $22.7 | $41.5 | $34.74 |
| Selling, general & administrative | $34.25 | $30.05 | $30.02 | $34.26 |
| Total operating expenses | $60.56 | $52.74 | $71.52 | $68.99 |
| Operating income | -$7.85 | -$13.85 | -$11.77 | -$17.26 |
| Income from continuing operations | ||||
| EBIT | -$7.87 | -$13.45 | -$11.41 | -$17.16 |
| Income tax expense | ||||
| Interest expense | $4.86 | $4.82 | $4.17 | $4.87 |
| Net income | ||||
| Net income | -$12.73 | -$18.28 | -$15.58 | -$22.03 |
| Income (for common shares) | -$12.73 | -$18.28 | -$15.58 | -$22.03 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $229.97 | $238.65 | $173.32 | $99.24 |
| Cost of revenue | $19.15 | $17.2 | $16.09 | $8.43 |
| Gross Profit | $210.82 | $221.44 | $157.23 | $90.81 |
| Operating activities | ||||
| Research & development | $134.63 | $159.71 | $116.76 | $99.91 |
| Selling, general & administrative | $130.51 | $144.15 | $152.7 | $184.16 |
| Total operating expenses | $265.14 | $303.87 | $269.46 | $294.88 |
| Operating income | -$54.32 | -$82.42 | -$112.23 | -$204.06 |
| Income from continuing operations | ||||
| EBIT | -$51.92 | -$81.23 | -$108.06 | -$198.38 |
| Income tax expense | ||||
| Interest expense | $18.25 | $27.98 | $24.93 | $22.95 |
| Net income | ||||
| Net income | -$70.18 | -$109.21 | -$132.99 | -$221.34 |
| Income (for common shares) | -$70.18 | -$109.21 | -$132.99 | -$221.34 |
| (in millions $) | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 |
|---|---|---|---|---|
| Net income | -$12.73 | -$18.28 | -$15.58 | -$22.03 |
| Operating activities | ||||
| Depreciation | $0.39 | $0.39 | $0.39 | $0.28 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $5.23 | $4.14 | $5.59 | $6.08 |
| Total cash flows from operations | $1.07 | -$40.24 | $1.76 | $9.91 |
| Investing activities | ||||
| Capital expenditures | -$0.19 | -$0.16 | -$0.03 | |
| Investments | ||||
| Total cash flows from investing | -$0.19 | -$0.16 | -$0.03 | |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.48 | $0.24 | $0.48 | |
| Net borrowings | $2.31 | |||
| Total cash flows from financing | $0.48 | $0.24 | $0.48 | |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $0.88 | -$39.92 | $1.97 | $10.39 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Net income | -$70.18 | -$109.21 | -$132.99 | -$221.34 |
| Operating activities | ||||
| Depreciation | $1.16 | $1.69 | $2.31 | $2.87 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $22.79 | $24.7 | $23.61 | $28.7 |
| Total cash flows from operations | -$22.43 | -$73.95 | -$82.41 | -$204.73 |
| Investing activities | ||||
| Capital expenditures | -$0.03 | -$0.18 | ||
| Investments | $23.24 | $67.48 | $87.28 | $134.5 |
| Total cash flows from investing | $23.21 | $67.48 | $87.28 | $134.32 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $5.2 | $3.11 | $5.71 | $11.67 |
| Net borrowings | $16.43 | $25 | ||
| Total cash flows from financing | $19.32 | $28.01 | $5.71 | $11.67 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $20.1 | $21.55 | $10.57 | -$58.74 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 47.61M |
| Revenue | $223.36M |
|---|---|
| EBITDA | -$48.46M |
| EBIT | -$49.90M |
| Net Income | -$68.63M |
| Revenue Q/Q | 12.53% |
| Revenue Y/Y | -10.18% |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | -5.74 |
| Cash/Share | 1.53 |
| EPS | -$1.44 |
|---|---|
| ROA | -40.59% |
| ROE | 26.54% |
| Debt/Equity | -1.72 |
|---|---|
| Net debt/EBITDA | -7.32 |
| Current ratio | 1.67 |
| Quick ratio | 1.52 |